Ogier advised life sciences-focused investment firm Medicxi on the launch of Medicxi III.
In a first and final close, Medicxi raised €400 million from more than 40 investors, including a significant number of new institutional limited partners. Medicxi III, which is established as a Jersey Expert Fund, will make equity and equity-related investments primarily in European and Europe-originated life sciences companies targeting primarily pre-clinical and clinical stage private companies. This brings the total amount raised by Medicxi in the last three years to over $1 billion.
Ogier advised with a team including Niamh Lalor (Picture), Alexandra O’Grady and Emilie Rowson.
Law Firms: Ogier LLP;
Clients: Medicxi Ventures;